Skip to main content
Top
Published in: Clinical Rheumatology 12/2015

01-12-2015 | Brief Report

Primary care assessment of capillaroscopy abnormalities in patients with Raynaud’s phenomenon

Authors: Rebecca Overbury, Maureen A. Murtaugh, Aryeh Fischer, Tracy M. Frech

Published in: Clinical Rheumatology | Issue 12/2015

Login to get access

Abstract

Raynaud’s phenomenon is a clinical symptom that can commonly present to a primary care provider or generalist. Proper identification of an underlying connective tissue disease in a patient with Raynaud’s could allow for the prevention of possible critical digital ischemia. Capillaroscopy is a tool which can identify abnormalities associated with connective tissue disease. Patients presenting with a complaint of Raynaud’s phenomenon were assessed with capillaroscopy. In twenty consecutive Raynaud patients, 8 digits were assessed by a ×200 magnification dermatoscope and an image was obtained. Each image was assessed for the following abnormalities: drop-out (<9 capillaries in 1 mm); microhemorrhage; dilated loops; and neoangiogenesis. These 160 images were then shown to 20 primary care physicians, who assessed these same abnormalities. The interrater reliability, a measure of agreement, of individual primary care providers with the expert provider was assessed using kappa statistics. Three raters had slight agreement (in the range 0 to 0.20), one rater had fair agreement (0.21 to 0.40), 11 raters had moderate agreement (0.41 to 0.60), five raters had substantial agreement (0.61 to 0.80), and no rater had almost perfect agreement (0.81 to 1.00) (14). The total agreement from the 20 primary care providers (n = 3,156) was moderate (Κ = 0.50, 95 % CI 0.49, 0.55). For the four providers with the slight to fair interrater reliabilities, the most common disagreement was providing a positive diagnosis when the expert rater diagnosed the digit negative. Ten of the twenty primary care providers provided at least one additional diagnosis following an abnormal diagnosis (n = 35 digits or 35 % of the 1556 abnormal ratings by the primary care providers). The four providers with the poorest interrater reliabilities were not among the ten providers who participated in making these additional specific diagnoses. These providers achieved the moderate agreement with the expert provider for diagnoses of microhemorrhage (Κ = 0.64, 95 % CI 0.57, 0.70), but fair agreement with the expert provider for diagnoses of dilated (Κ = 0.27, 95 % CI 0.20, 0.34) and neoangiogenesis (Κ = 0.22, 95 %CI 0.13, 0.31). Capillaroscopy is a potentially contributive clinical exam skill that could assist primary care providers and generalists in identifying and qualifying changes associated with the common presentation of Raynaud’s disease. However, formal training is needed to ensure accuracy and reproducibility. Furthermore, training and scoring systems should address time constraints of busy primary care practitioners.
Literature
1.
go back to reference Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI et al (1989) Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 32(8):998–1006CrossRefPubMed Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI et al (1989) Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 32(8):998–1006CrossRefPubMed
2.
go back to reference Chatterjee S (2013) Q: when do Raynaud symptoms merit a workup for autoimmune rheumatic disease? Cleve Clin J Med 80(1):22–25CrossRefPubMed Chatterjee S (2013) Q: when do Raynaud symptoms merit a workup for autoimmune rheumatic disease? Cleve Clin J Med 80(1):22–25CrossRefPubMed
3.
4.
go back to reference Stevens W, Nikpour M, Byron J, Roddy J, Sahhar J, Zochling J et al (2011) Frequency, clinical characteristics and risk factors for digital ulcers in systemic sclerosis. Int Med J 41(Suppl 1):13 Stevens W, Nikpour M, Byron J, Roddy J, Sahhar J, Zochling J et al (2011) Frequency, clinical characteristics and risk factors for digital ulcers in systemic sclerosis. Int Med J 41(Suppl 1):13
5.
go back to reference Beltrán E, Toll A, Pros A, Carbonell J, Pujol RM (2007) Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon. Br J Dermatol 156(5):892–898CrossRefPubMed Beltrán E, Toll A, Pros A, Carbonell J, Pujol RM (2007) Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon. Br J Dermatol 156(5):892–898CrossRefPubMed
6.
go back to reference Cutolo M, Sulli A, Smith V (2013) How to perform and interpret capillaroscopy. Best Pract Res Clin Rheumatol 27(2):237–248CrossRefPubMed Cutolo M, Sulli A, Smith V (2013) How to perform and interpret capillaroscopy. Best Pract Res Clin Rheumatol 27(2):237–248CrossRefPubMed
7.
go back to reference Baron M, Bell M, Bookman A, Buchignani M, Dunne J, Hudson M et al (2007) Office capillaroscopy in systemic sclerosis. Clin Rheumatol 26(8):1268–1274CrossRefPubMed Baron M, Bell M, Bookman A, Buchignani M, Dunne J, Hudson M et al (2007) Office capillaroscopy in systemic sclerosis. Clin Rheumatol 26(8):1268–1274CrossRefPubMed
8.
9.
go back to reference van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747–1755CrossRefPubMed van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747–1755CrossRefPubMed
10.
go back to reference Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C et al (2013) Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J Rheumatol 40(12):2023–2028CrossRefPubMed Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C et al (2013) Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J Rheumatol 40(12):2023–2028CrossRefPubMed
11.
go back to reference Cutolo M, Smith V (2013) State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology? Rheumatology (Oxford) 52(11):1933–1940CrossRef Cutolo M, Smith V (2013) State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology? Rheumatology (Oxford) 52(11):1933–1940CrossRef
12.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed
Metadata
Title
Primary care assessment of capillaroscopy abnormalities in patients with Raynaud’s phenomenon
Authors
Rebecca Overbury
Maureen A. Murtaugh
Aryeh Fischer
Tracy M. Frech
Publication date
01-12-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3062-3

Other articles of this Issue 12/2015

Clinical Rheumatology 12/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.